Aspirin after preeclampsia: could a simple pill protect Women's hearts?

NCT ID NCT06168461

Recruiting now Disease control Sponsor: Anna Stanhewicz, PhD Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

Women who had preeclampsia are four times more likely to develop heart disease later in life, possibly due to lasting blood vessel damage. This early-phase trial tests whether taking low-dose aspirin (162 mg daily) can improve blood vessel function in 40 women who had preeclampsia within the past five years. Researchers will measure how well blood vessels respond to certain signals, comparing aspirin to a placebo.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Aspirin
What this could lead to: If it works, this could point toward a simple, low-cost treatment to lower heart disease risk in women who had preeclampsia.
What could go wrong: This is a very early, small trial (40 people) testing short-term effects on blood vessel function, not long-term heart health. Aspirin may not provide lasting benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREECLAMPSIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

preeclampsia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PREECLAMPSIA

Contacts and locations

Locations

University of Iowa
RECRUITING

Iowa City, Iowa, 52242, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.